Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Pathology

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 26617828PMCID PMC4637643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Cancer cell-derived IL-8 induces monocytic THP1 cells to secrete IL-8 via the mitogen-activated protein kinase pathway

  2015cited by this paper
• Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer.

  2015cited by this paper
• RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.

  2015cited by this paper
• Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells

  2015cited by this paper
• Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.

  2015cited by this paper
• Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

  2015cited by this paper
• The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1

  2014cited by this paper
• Abstract 5005: The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1

  2014cited by this paper
• Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.

  2014cited by this paper
• Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype.

  2014cited by this paper
• MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway

  2014cited by this paper
• Current questions for the treatment of advanced gastric cancer.

  2013cited by this paper
• The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma

  2013cited by this paper
• Role of the Hypoxia-Related Gene, JMJD1A, in Hepatocellular Carcinoma: Clinical Impact on Recurrence after Hepatic Resection

  2012cited by this paper
• The expression of histone demethylase JMJD1A in renal cell carcinoma.

  2011cited by this paper
• Jumonji Domain Containing 1A Is a Novel Prognostic Marker for Colorectal Cancer: In vivo Identification from Hypoxic Tumor Cells

  2010cited by this paper
• Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

  2010cited by this paper
• Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.

  2010cited by this paper
• Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling*

  2009cited by this paper
• Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1α Enhances Hypoxic Gene Expression and Tumor Growth

  2009cited by this paper
• Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

  2008cited by this paper
• The role of chromatin during transcription.

  2007cited by this paper
• Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis

  2007cited by this paper
• JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.

  2006influential reference

• KDM3A Modulates Trastuzumab Resistance in HER2- Positive Breast Cancer Cells via the PI3K/AKT/ERK Pathway.

  2025cites this paper
• Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression.

  2023cites this paper
• KDM3A, a Novel Blood-Based Biomarker in Colorectal Carcinogenesis

  2022cites this paper
• JMJD family proteins in cancer and inflammation

  2022cites this paper
• Histone demethylase JMJD1A in cancer progression and therapeutic resistance

  2022cites this paper
• Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer

  2020cites this paper
• The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition

  2020cites this paper
• MAP Kinases Pathways in Gastric Cancer

  2020cites this paper
• Histone demethylase Jumonji domain‐containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt‐related transcription factor 3

  2020cites this paper
• Epigenetic Approaches to the Treatment of Renal Cell Cancer

  2020cites this paper
• Histone demethylase JMJD1A inhibits proliferation and progression of gastric cancer by up-regulating RUNX3.

  2020cites this paper
• Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities

  2020cites this paper
• KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.

  2019cites this paper
• Inhibition of G9a promoted 5-fluorouracil (5-FU) induced gastric cancer cell apoptosis via ROS/JNK signaling pathway in vitro and in vivo

  2019cites this paper
• JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma

  2018cites this paper
• KDM3A is not associated with metastasis and prognosis of breast cancer

  2018cites this paper
• BRG1 regulates NOX gene transcription in endothelial cells and contributes to cardiac ischemia-reperfusion injury.

  2018cites this paper
• H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression

  2018cites this paper
• Long non-coding RNAs involved in metastasis of gastric cancer

  2018cites this paper
• Hypoxia-inducible KDM3A addiction in multiple myeloma.

  2018cites this paper
• Long non-coding RNA-mediated regulation of signaling pathways in gastric cancer

  2018cites this paper
• The histone demethylase Kdm3a is required for normal epithelial proliferation, ductal elongation and tumor growth in the mouse mammary gland

  2017cites this paper
• Imaging of Renal Medullary Carcinoma

  2017cites this paper
• Serum MALAT 1 expression predicts clinical outcome in breast cancer patients receiving cyclophosphamide based treatment

  2017cites this paper
• The Molecular Basis of Histone Demethylation

  2017cites this paper
• LncRNAs act as prognostic biomarkers in gastric cancer: A systematic review and meta-analysis

  2017cites this paper
• Methylation modification in gastric cancer and approaches to targeted epigenetic therapy (Review).

  2017cites this paper
• The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis

  2017cites this paper
• Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease

  2017cites this paper
• The Emerging Role of Histone Demethylases in Renal Cell Carcinoma

  2017cites this paper
• Microarray expression profile analysis of aberrant long non-coding RNAs in esophageal squamous cell carcinoma.

  2016cites this paper
• Jumonji domain-containing protein 1A promotes cell growth and progression via transactivation of c-Myc expression and predicts a poor prognosis in cervical cancer

  2016cites this paper